PIETROLONGO, ERIKA
 Distribuzione geografica
Continente #
NA - Nord America 1.002
EU - Europa 998
AS - Asia 438
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 2.442
Nazione #
US - Stati Uniti d'America 1.000
CN - Cina 253
IT - Italia 240
IE - Irlanda 170
UA - Ucraina 160
TR - Turchia 128
GB - Regno Unito 111
SE - Svezia 99
FR - Francia 91
DE - Germania 68
FI - Finlandia 39
IN - India 38
IR - Iran 9
DK - Danimarca 7
BE - Belgio 6
VN - Vietnam 5
ES - Italia 3
EU - Europa 3
CA - Canada 2
KR - Corea 2
AT - Austria 1
AU - Australia 1
IL - Israele 1
MD - Moldavia 1
NO - Norvegia 1
PH - Filippine 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 2.442
Città #
Jacksonville 231
Chandler 171
Dublin 170
Southend 104
Princeton 85
Nanjing 78
Izmir 59
Beijing 57
Ashburn 46
Ann Arbor 38
Cambridge 36
Dearborn 34
Wilmington 31
Altamura 29
New York 22
Nanchang 20
Kunming 16
Chieti 15
Grevenbroich 15
Torino 14
Jiaxing 12
Norwalk 12
Hebei 11
Los Angeles 10
Milan 10
Shenyang 10
Monmouth Junction 9
Rome 9
Washington 9
Ardabil 7
Jinan 7
Leawood 7
San Mateo 7
Brussels 6
Codogno 6
Genova 6
Taizhou 6
Tianjin 6
Boardman 5
Changchun 5
Dong Ket 5
Guangzhou 5
Viby J 5
Andover 4
Falls Church 4
Genoa 4
Hangzhou 4
San Vito Chietino 4
Woodbridge 4
Benevento 3
Campobasso 3
Changsha 3
Helsinki 3
Lanzhou 3
Parma 3
Bari 2
Campomorone 2
Cecina 2
Dolo 2
Fairfield 2
Florence 2
Hanover 2
Houston 2
Monzuno 2
Mountain View 2
Mumbai 2
Naples 2
Ningbo 2
Piacenza 2
Portico Di Caserta 2
Redmond 2
Redwood City 2
Seattle 2
Signa 2
Somma Lombardo 2
Tappahannock 2
Toronto 2
Trieste 2
Turin 2
Umbertide 2
Almese 1
Angri 1
Atlanta 1
Augusta 1
Brisbane 1
Calenzano 1
Carlentini 1
Caserta 1
Cassano Magnago 1
Chengdu 1
Chicago 1
Desio 1
Edinburgh 1
Enna 1
Erice 1
Frankfurt am Main 1
Fuzhou 1
Inveruno 1
Manchester 1
Manila 1
Totale 1.558
Nome #
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population 150
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Normative Values With Gender, Age And Education Corrections In The Italian Population (P5.015) 99
The brief international cognitive assessment for multiple sclerosis (bicams): normative values in the Italian population. 89
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 82
Data of safety in a single-center alemtuzumab treated population 77
Increasing age at disability milestones among MS patients in the MSBase Registry 76
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 75
Home-based palliative approach for people with severe multiple sclerosis and their carers: Study protocol for a randomized controlled trial 72
Patterns in patients’expression of emotions and neurologists’ response. 71
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 70
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study 70
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 66
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 66
A comparison of the Brief International Cognitive Assessment for Multiple Sclerosis and a brief repeatable battery in multiple sclerosis patients. 64
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 63
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 62
JCV-Ab serostatus in MS patients treated with Natalizumab 62
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 62
Decision-Making in Multiple Sclerosis Consultations in Italy: Third Observer and Patient Assessments 61
Natalizumab-associated PML-IRIS: the Chieti experience. 61
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 60
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 59
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 56
Decidere la maternità. Un ausilio per le donne con SM 54
Role preferences of relapsing MS patient in Italy 54
The Italian version of the Motherhood choice: a decision aid for women with MS considering motherhood 53
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 53
Unmet needs of people with severe multiple sclerosis and their carers: qualitative findings for a home-based intervention. 53
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 52
Assessing subjective quality of life domains after multiple sclerosis diagnosis disclosure 51
Well-being and health-related quality of life among persons with multiple sclerosis, caregivers and health professionals: a comparative study 50
Illness Perception and Well-Being Among Persons with Multiple Sclerosis and Their Caregivers. 46
Patient expression of emotions and neurologist responses in first multiple sclerosis consultations 46
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis 45
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 41
Unmet needs of people with severe multiple sclerosis and their carers: qualitative data to construct a home palliative care program 41
The Care system: well-being promotion among people with multiple sclerosis, caregivers and health professionals 40
Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis 37
Sapere Migliora : informazioni sulla SM per la persona neodiagnosticata 36
The coexistence of well- and ill-being in persons with multiple sclerosis, their caregivers and health professionals. 34
Randomized controlled trial of a home-based palliative approach for people with severe multiple sclerosis 30
Participant perspectives of a home-based palliative approach for people with severe multiple sclerosis: A qualitative study 18
Totale 2.507
Categoria #
all - tutte 8.264
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.264


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201991 0 0 0 0 0 0 0 0 0 0 1 90
2019/2020520 155 38 6 0 40 30 64 53 8 61 60 5
2020/2021263 46 12 52 4 5 42 6 6 30 13 39 8
2021/2022179 5 2 5 32 6 4 15 14 11 10 24 51
2022/2023528 54 81 29 38 50 105 32 32 80 7 11 9
2023/2024279 20 7 25 10 25 106 48 4 12 22 0 0
Totale 2.507